October 9, 2024 – OrthoSpineNews – Foot Innovate is pleased to announce Kuros Biosciences as its newest corporate partner. Kuros Biosciences is dedicated to discovering, developing and delivering innovative biologic fusion technologies. With locations in the United States, Netherlands, and Switzerland, the company is listed on the SIX Swiss Exchange (SW:KURN).
Kuros Biosciences’ platform product, MagnetOs, is a unique advanced bone graft that has been used in over 25,000 fusion surgeries across three continents. For more information, visit kurosbio.com.
“We are excited to partner with Foot Innovate, a leading platform for disseminating scientific knowledge in the foot and ankle industry,” said Chris Fair, CEO of Kuros Biosciences. “As a leader in the advanced bone graft market, we believe our MagnetOs platform is uniquely positioned to deliver meaningful clinical benefits in foot and ankle fusion procedures.”
This partnership reinforces Foot Innovate’s commitment to delivering the latest research, surgical techniques, and innovative products to the foot and ankle community.
About Foot Innovate:
Foot Innovate (www.footinnovate.com) is a premier online platform developed by surgeons to meet the educational needs of medical professionals. As the leading resource for foot and ankle education, Foot Innovate provides access to the latest surgical techniques, medical devices, and treatment protocols through its members, contributors, and corporate partners. Our mission is to support healthcare professionals worldwide in advancing their clinical knowledge and expertise.
Contact:
Beverly Williams
Email: bwilliams@footinnovate.com
